Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis

Cesare Hassan, A Zullo, A Andriani, F Cristofari, V De Francesco, E Ierardi, S Tomao, S Morini, D. Vaira

Risultato della ricerca: Contributo in rivistaArticolo in rivista

73 Citazioni (Scopus)

Abstract

Helicobacter pylori eradication is recognized as the initial therapy for gastric low-grade, B-cell, mucosa-associated lymphoid tissue (MALT) lymphoma. This study assesses (i) the H. pylori eradication rates for various first- and second-line and rescue therapies and (ii) the associated reinfection rates in patients.
Lingua originaleEnglish
pagine (da-a)1932-1932-7; quiz 1938
RivistaAmerican Journal of Gastroenterology
Volume104
DOI
Stato di pubblicazionePubblicato - 2009
Pubblicato esternamente

Keywords

  • Drug Therapy, Combination
  • Helicobacter Infections
  • Helicobacter pylori
  • Humans
  • Lymphoma, B-Cell, Marginal Zone
  • Recurrence
  • Statistics as Topic
  • Stomach Neoplasms

Fingerprint

Entra nei temi di ricerca di 'Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis'. Insieme formano una fingerprint unica.

Cita questo